Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1945 3
1946 1
1947 5
1948 6
1949 5
1950 10
1951 14
1952 5
1953 14
1954 27
1955 19
1956 19
1957 11
1958 16
1959 28
1960 22
1961 17
1962 20
1963 48
1964 80
1965 48
1966 65
1967 104
1968 103
1969 116
1970 102
1971 120
1972 157
1973 114
1974 115
1975 95
1976 96
1977 94
1978 110
1979 109
1980 116
1981 105
1982 138
1983 158
1984 148
1985 190
1986 172
1987 180
1988 213
1989 259
1990 264
1991 251
1992 285
1993 329
1994 437
1995 469
1996 413
1997 507
1998 559
1999 548
2000 578
2001 586
2002 542
2003 605
2004 707
2005 750
2006 896
2007 918
2008 1102
2009 1361
2010 1605
2011 1848
2012 2179
2013 2368
2014 2673
2015 2969
2016 3056
2017 3343
2018 3480
2019 3758
2020 4026
2021 4563
2022 4466
2023 4291
2024 1896

Text availability

Article attribute

Article type

Publication date

Search Results

56,267 results

Results by year

Filters applied: . Clear all
Page 1
A comprehensive profile of recurrent glioblastoma.
Campos B, Olsen LR, Urup T, Poulsen HS. Campos B, et al. Oncogene. 2016 Nov 10;35(45):5819-5825. doi: 10.1038/onc.2016.85. Epub 2016 Apr 4. Oncogene. 2016. PMID: 27041580 Review.
Remarkably, however, fundamental knowledge on the biology of recurrent glioblastoma is just slowly emerging. Here, we review current knowledge on recurrent glioblastoma and ask whether and how therapies change intra-tumor heterogeneity, molecular traits and growth p …
Remarkably, however, fundamental knowledge on the biology of recurrent glioblastoma is just slowly emerging. Here, we review current …
Molecular Mechanisms of Treatment Resistance in Glioblastoma.
Ou A, Yung WKA, Majd N. Ou A, et al. Int J Mol Sci. 2020 Dec 31;22(1):351. doi: 10.3390/ijms22010351. Int J Mol Sci. 2020. PMID: 33396284 Free PMC article. Review.
Glioblastoma is the most common malignant primary brain tumor in adults and is almost invariably fatal. ...Here, we review the innate and adaptive molecular mechanisms underlying glioblastoma's treatment resistance, emphasizing the intrinsic challenges therapeutic i …
Glioblastoma is the most common malignant primary brain tumor in adults and is almost invariably fatal. ...Here, we review the innate …
Glioblastoma: Changing concepts in the WHO CNS5 classification.
Chen J, Han P, Dahiya S. Chen J, et al. Indian J Pathol Microbiol. 2022 May;65(Supplement):S24-S32. doi: 10.4103/ijpm.ijpm_1109_21. Indian J Pathol Microbiol. 2022. PMID: 35562131 Free article. Review.
Glioblastoma is the most common malignant central nervous system (CNS) tumor in adults. ...Besides these common features, several well-recognized histological subtypes include giant cell glioblastoma, granular cell glioblastoma, gliosarcoma, glioblastoma …
Glioblastoma is the most common malignant central nervous system (CNS) tumor in adults. ...Besides these common features, several wel …
The prognosis of glioblastoma: a large, multifactorial study.
Luo C, Song K, Wu S, Hameed NUF, Kudulaiti N, Xu H, Qin ZY, Wu JS. Luo C, et al. Br J Neurosurg. 2021 Oct;35(5):555-561. doi: 10.1080/02688697.2021.1907306. Epub 2021 Jul 8. Br J Neurosurg. 2021. PMID: 34236262
OBJECTIVE: Glioblastoma is the most common and fatal primary brain tumor in adults. ...In addition, the prognosis of glioblastoma patients with total resection was significantly better than that of glioblastoma patients with sub-total resection or biopsy. ...
OBJECTIVE: Glioblastoma is the most common and fatal primary brain tumor in adults. ...In addition, the prognosis of glioblastoma …
Glioblastoma.
Penas-Prado M, Armstrong TS, Gilbert MR. Penas-Prado M, et al. Handb Clin Neurol. 2012;105:485-506. doi: 10.1016/B978-0-444-53502-3.00004-5. Handb Clin Neurol. 2012. PMID: 22230514 Review. No abstract available.
Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment.
Hernández A, Domènech M, Muñoz-Mármol AM, Carrato C, Balana C. Hernández A, et al. Cells. 2021 Dec 14;10(12):3529. doi: 10.3390/cells10123529. Cells. 2021. PMID: 34944036 Free PMC article. Review.
Glioblastoma (GBM) is the most aggressive brain tumor in adults and is characterized by an immunosuppressive microenvironment. ...
Glioblastoma (GBM) is the most aggressive brain tumor in adults and is characterized by an immunosuppressive microenvironment. ...
Immunotherapy in Glioblastoma.
Wilcox JA, Ramakrishna R, Magge R. Wilcox JA, et al. World Neurosurg. 2018 Aug;116:518-528. doi: 10.1016/j.wneu.2018.04.020. World Neurosurg. 2018. PMID: 30049046 Review.
Glioblastoma evades conventional therapies through a variety of mechanisms, including suppression of the immune system. ...Although immunotherapy has already demonstrated efficacy for a variety of other malignancies, its efficacy in glioblastoma is still unclear. Id …
Glioblastoma evades conventional therapies through a variety of mechanisms, including suppression of the immune system. ...Although i …
Radiomics for precision medicine in glioblastoma.
Aftab K, Aamir FB, Mallick S, Mubarak F, Pope WB, Mikkelsen T, Rock JP, Enam SA. Aftab K, et al. J Neurooncol. 2022 Jan;156(2):217-231. doi: 10.1007/s11060-021-03933-1. Epub 2022 Jan 12. J Neurooncol. 2022. PMID: 35020109 Review.
INTRODUCTION: Being the most common primary brain tumor, glioblastoma presents as an extremely challenging malignancy to treat with dismal outcomes despite treatment. ...CONCLUSION: Radiomics has the potential to transform the scope of glioblastoma management throug …
INTRODUCTION: Being the most common primary brain tumor, glioblastoma presents as an extremely challenging malignancy to treat with d …
Mouse Models of Experimental Glioblastoma.
Jin F, Jin-Lee HJ, Johnson AJ. Jin F, et al. In: Debinski W, editor. Gliomas [Internet]. Brisbane (AU): Exon Publications; 2021 Apr 30. Chapter 2. In: Debinski W, editor. Gliomas [Internet]. Brisbane (AU): Exon Publications; 2021 Apr 30. Chapter 2. PMID: 34038046 Free Books & Documents. Review.
Glioblastoma is one of the most common malignant brain tumors. It has poor prognosis: the survival rate is 14-15 months, even with treatment by surgery, radiation, and chemotherapy. ...The traditional Cre-LoxP system specifically targets glioblastoma-related genes b …
Glioblastoma is one of the most common malignant brain tumors. It has poor prognosis: the survival rate is 14-15 months, even with tr …
56,267 results
You have reached the last available page of results. Please see the User Guide for more information.